Ganglioglioma staging

	Ganglioglioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Ganglioglioma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ganglioglioma staging On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ganglioglioma staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onGanglioglioma staging
CDC on Ganglioglioma staging
Ganglioglioma staging in the news
on Ganglioglioma staging
Directions to Hospitals Treating Ganglioglioma
Risk calculators and risk factors for Ganglioglioma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

According to the WHO classification of central nervous system (CNS) tumors, ganglioglioma is staged as low grade (WHO Grade I or II) CNS tumors.

According to the WHO classification of central nervous system (CNS) tumors, ganglioglioma is staged as low grade (WHO Grade I or II) CNS tumors.